News
- Author:
- Jim Kling
Publish date: December 16, 2022
A study in San Antonio suggests low insurance coverage rates may be at least partially to blame.
News
- Author:
- Jim Kling
Publish date: December 16, 2022
Black patients were more likely to be diagnosed with triple-negative breast cancer than White patients.
News
- Author:
- Jim Kling
Publish date: December 16, 2022
The survival advantage was present in all patients under 50 years old.
News
- Author:
- Jim Kling
Publish date: December 1, 2022
Whole breast radiation can cut treatment time from 6 weeks down to 3 weeks.
News
- Author:
- Jim Kling
Publish date: November 29, 2022
Immunotherapy benefits locally advanced HPV-positive oropharyngeal cancer in phase 2 study.
News
- Author:
- Jim Kling
Publish date: November 29, 2022
A qualitative study in California reveals challenges and attitudes that could be addressed with new melanoma outreach and prevention strategies.
News
- Author:
- Jim Kling
Publish date: November 28, 2022
Phase 2 trial achieves some success, and responders had infiltrate of plasmacytoid dendritic cells.
News
- Author:
- Jim Kling
Publish date: November 28, 2022
Cellular packaging may also help evade the immune response.
News
- Author:
- Jim Kling
Publish date: November 28, 2022
A phase 1 trial shows good clinical response after transplants from healthy donors.
News
- Author:
- Jim Kling
Publish date: November 28, 2022
Visual analysis combined with submucosal invasive cancer risk stratification boosted the frequency of curative resection after endoscopic submucosa...
News
- Author:
- Jim Kling
Publish date: November 28, 2022
Update focuses on expanded eligibility and newer techniques.
News
- Author:
- Jim Kling
Publish date: November 23, 2022
Phase 2 clinical trial shows consistent benefits at all levels of PD-L1 expression.
News
- Author:
- Jim Kling
Publish date: November 14, 2022
Authors of a systematic review suggest ICI combinations should be available worldwide as first-line treatment for advanced renal cancer.
News
- Author:
- Jim Kling
Publish date: November 13, 2022
Radiation oncologists at ASTRO 2022 discuss practical applications of AI, and new research findings.
News
- Author:
- Jim Kling
Publish date: November 13, 2022
High allostatic load was associated with an 80% increased risk of cancer death among all study participants.
